| Audio Data Collection for Identification and Classification of Coughing (NCT04326309) | HealthMode Inc. | 2020-03-25 |
| Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. (NCT04622917) | Karolinska Institutet | 2019-04-10 |
| Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis (NCT03724240) | ASIT Biotech S.A. | 2019-01-02 |
| Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis (NCT02560948) | BioTech Tools S.A. | 2015-12-01 |
| Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM (NCT02156791) | BioTech Tools S.A. | 2013-08-01 |
| Observational Study With PASCALLERG ® in Patients With Hay Fever (NCT01660737) | Pascoe Pharmazeutische Praeparate GmbH | 2012-02-01 |
| Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant (NCT01506375) | BioTech Tools S.A. | 2011-11-01 |
| Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis (NCT01308021) | BioTech Tools S.A. | 2010-12-01 |
| Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) (NCT01024608) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-12-31 |
| Probiotics for Reduction Of Markers In Subjects With Allergy (NCT01137357) | Rijnstate Hospital | 2008-11-01 |
| Evaluation of High Speed Laser Doppler Imaging Technology (NCT02619331) | Centre Hospitalier Universitaire Vaudois | 2008-02-01 |
| Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR (NCT00574379) | Faes Farma, S.A. | 2007-12-01 |
| PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) (NCT00574210) | Faes Farma, S.A. | 2007-10-01 |
| A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413) (NCT00384475) | AstraZeneca | 2006-10-01 |
| Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) (NCT00261287) | AstraZeneca | 2005-11-01 |
| Safety and Efficacy Study of rEV131 in Allergic Rhinitis (NCT00247520) | Evolutec Group | 2005-05-01 |
| Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407) (NCT00659503) | AstraZeneca | 2005-02-01 |
| Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) (NCT00163488) | AstraZeneca | 2005-01-01 |
| Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406) (NCT00659594) | AstraZeneca | 2004-11-01 |
| To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) (NCT00658918) | AstraZeneca | 2004-09-01 |
| Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders (NCT00189917) | Bavarian Nordic | 2004-04-01 |
| Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) (NCT00163501) | AstraZeneca | 2003-12-01 |
| To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) (NCT00659841) | AstraZeneca | 2003-12-01 |
| Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies (NCT00078195) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) (NCT02932774) | Johnson & Johnson Consumer and Personal Products Worldwide | 2001-03-01 |